MarketPulse
E

$EDIT

2 articles found
1 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Neutrolis Bolsters Leadership with Seasoned Biotech Veteran Deardorf as Chief Strategy Officer

Clinical-stage biotech Neutrolis appoints Caren Deardorf as Chief Business & Strategy Officer, bringing 30 years of pharma commercialization expertise as company advances NTR-1011 candidate.
EDITCRNXautoimmune diseasescommercialization
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Editas Medicine Slashes Q4 Losses While Advancing CRISPR Therapy Toward Human Trials

Editas Medicine reported Q4 2025 net loss of $5.6M, down 88% YoY. Lead CRISPR therapy EDIT-401 shows >90% LDL-C reduction; IND submission expected mid-2026.
BMYCELGrEDITclinical trialCRISPR